Status:
COMPLETED
Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to observe the effects of certain anti-HIV medications on mitochondrial activity and fat cell death. This study will enroll participants from another study, ACTG A5202, wh...
Detailed Description
The main objective of this study is to observe the effects of anti-HIV medication lacking thymidine on mitochondrial metabolism and adipocyte apoptosis (fat cell death). Changes in mitochondrial metab...
Eligibility Criteria
Inclusion
- HIV-infected
- Enrolling in ACTG A5202 and its metabolic substudy ACTG A5224
Exclusion
- Bleeding problems
- Cannot undergo fat biopsies
- Require aspirin anytime in the 7-day period prior to each biopsy
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00433992
Start Date
April 1 2006
End Date
December 1 2009
Last Update
September 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Case School of Medicine
Cleveland, Ohio, United States, 44106